Delivery Order SPE2DB22D2007-SPE2DB25FJ5KS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,183.90 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,351.37 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of ENBREL 50 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,858.46 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-competitive award under the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injector pharmaceutical product. This competitive delivery order, valued at $10,386.51 with firm fixed pricing, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award carries an ultimate completion date of September 11, 2025, and involves no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,459.45 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price, non-set-aside delivery order is expected to be completed by June 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,960.45 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This non-competitive, firm fixed-price delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $112,020.29 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, issued on June 3, 2025, with an ultimate completion date of June 4, 2025, represents a non-competitive, competitively awarded transaction under an existing contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $11,055.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. The delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency (DLA) awarded a $35,072.01 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, with an ultimate completion date of August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is listed...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This competitively awarded, non-set-aside contract carries a ceiling value of $9,476.47 under firm fixed-price terms, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5KSDelivery Order
The Defense Logistics Agency (DLA) awarded a $22,930.02 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by September 29, 2025, with performance to be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that supports military healthcare operations globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio with the DLA encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order for Enbrel, a specialty biologic medication commonly used for rheumatologic conditions, exemplifies the type of brand-name pharmaceutical products the contractor routinely supplies through its established relationship with the federal military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.9k | 9/26/25 |